Reference
Yu H, et al. Single-institution experience of venetoclax combined with azacitidine in newly diagnosed acute myeloid leukemia patients. International Immunopharmacology 127 : 1-7, Jan 2024. Available from: URL: https://dx.doi.org/10.1016/j.intimp.2023.111232
Rights and permissions
About this article
Cite this article
Azacitidine/Venetoclax. Reactions Weekly 1992, 37 (2024). https://doi.org/10.1007/s40278-024-52770-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-024-52770-z